Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study

Míreanna Comhchosúla

• The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury—The Women’s Interagency HIV Study
  le: Keating, Sheila M., et al.
  Foilsithe: (2017)
• Enhanced Liver Fibrosis marker as a non-invasive predictor of mortality in HIV/HCV-coinfected women from the Women’s Interagency HIV Study
  le: Peters, Marion G., et al.
  Foilsithe: (2016)
• Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression among HIV-Infected Women Participating in the Women’s Interagency HIV Study (WIHS)
  le: French, Audrey L, et al.
  Foilsithe: (2017)
• Lower Liver-Related Death in African American Women With HIV/HCV Co-Infection Compared to Caucasian and Hispanic Women
  le: Sarkar, Monika, et al.
  Foilsithe: (2012)
• Prevalence of Clinical Symptoms Associated with Highly Active Antiretroviral Therapy in the Women’s Interagency HIV Study
  le: Silverberg, Michael J., et al.
  Foilsithe: (2004)